This uses your own stem cells, which are collected and then injected back into your body. Early results have been encouraging and understanding how best to treat people with stem cells is improving. AHSCT has not been formally assessed for use in the NHS outside clinical trials, but a small number of centres have begun to provide it on the NHS under specific circumstances to a very small number of people. People accepted for treatment generally either have a very aggressive type of MS or continue to have relapses even after trying one or more disease modifying drugs. Find out more about stem cells in this short film. Haematopoietic pronounced hee-mato-poy-etic stem cells are found mainly in our bone marrow, although small numbers circulate in our blood.
People with multiple sclerosis sometimes become desperate and will travel to other countries for experimental stem cell treatments. Faced with an incurable condition, people with multiple sclerosis will sometimes seek risky alternative treatments as their disabilities increase. And it comes with a high price. HSCT involves extracting white blood cells from the bone marrow of the person with multiple sclerosis MS. These cells are treated with chemotherapy to make them, in essence, forget they have MS. Stem cell tourism provides unproven stem cell treatments. In addition, there are more than clinics currently offering these unapproved treatments in the United States.
There is exciting and innovative research and progress occurring related to the potential of many types of stem cells for slowing MS disease activity and for repairing damage to the nervous system. In light of the urgent need for more effective treatments for MS, particularly for those with more progressive forms of the disease, we believe that the potential of all types of cell therapies must be explored. Stem cell therapy is any treatment that uses or targets stem cells, which are the types of cells that differentiate into many different specialized cells in our bodies.
Multiple sclerosis MS , a complex disorder of the central nervous system CNS , is characterized with axonal loss underlying long-term progressive disability. Currently available therapies for its management are able to slow down the progression but fail to treat it completely. Moreover, these therapies are associated with major CNS and cardiovascular adverse events, and prolonged use of these treatments may cause life-threatening diseases. Recent research has shown that cellular therapies hold a potential for CNS repair and may be able to provide protection from inflammatory damage caused after injury.